Literature DB >> 22010536

Is avian influenza virus A(H5N1) a real threat to human health?

A Amendola1, A Ranghiero, A Zanetti, E Pariani.   

Abstract

The A(H5N1) influenza remains a disease of birds with a significant species barrier: in the presence of some tens million cases of infection in poultry--with a wide geographical spread--, only a few hundreds cases have occurred in humans. To date, human cases have been reported in 15 countries--mainly in Asia--and all were related to the onset of outbreaks in poultry. A peak of H5N1 human cases was recorded in 2006, then decreasing in subsequent years. Despite this trend, the H5N1 virus still represents a possible threat to human health, considering that more than half of human cases of H5N1 have been fatal. Moreover, despite the drop in the number of cases, the risk of a novel pandemic cannot be excluded, since H5N1 continues to circulate in poultry in countries with elevated human population density and where monitoring systems are not fully appropriate. In addition, there is a major global concern about the potential occurrence of a reassortment between the 2009 pandemic H1N1 and the highly pathogenic H5N1 influenza viruses following a co-infection in a susceptible host. Therefore, the implementation of appropriate surveillance and containment measures is crucial in order to minimize such risk. In conclusion, H5N1 avian influenza is still a rare disease in humans but its clinical severe outcome requires a careful monitoring of the virus's ability to evolve and to trigger a new pandemic.

Entities:  

Mesh:

Year:  2011        PMID: 22010536

Source DB:  PubMed          Journal:  J Prev Med Hyg        ISSN: 1121-2233


  5 in total

Review 1.  A/H5N1 prepandemic influenza vaccine (whole virion, vero cell-derived, inactivated) [Vepacel®].

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2012-07-30       Impact factor: 9.546

2.  Possibility of cross-species/subtype reassortments in influenza A viruses: an analysis of nonstructural protein variations.

Authors:  Shaomin Yan; Guang Wu
Journal:  Virulence       Date:  2013-10-08       Impact factor: 5.882

3.  Induction of anti-influenza immunity by modified green fluorescent protein (GFP) carrying hemagglutinin-derived epitope structure.

Authors:  Yuji Inoue; Ritsuko Kubota-Koketsu; Akifumi Yamashita; Mitsuhiro Nishimura; Shoji Ideno; Ken-ichiro Ono; Yoshinobu Okuno; Kazuyoshi Ikuta
Journal:  J Biol Chem       Date:  2012-12-21       Impact factor: 5.157

4.  The viruses of wild pigeon droppings.

Authors:  Tung Gia Phan; Nguyen Phung Vo; Ákos Boros; Péter Pankovics; Gábor Reuter; Olive T W Li; Chunling Wang; Xutao Deng; Leo L M Poon; Eric Delwart
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

5.  Immunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza A virus.

Authors:  Shoji Ideno; Kaoru Sakai; Mikihiro Yunoki; Ritsuko Kubota-Koketsu; Yuji Inoue; Shota Nakamura; Teruo Yasunaga; Yoshinobu Okuno; Kazuyoshi Ikuta
Journal:  Biologics       Date:  2013-11-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.